Selected as a conducting company of ‘global high-tech biomedicine industry’

What is “CARTISTEM” used for treatment of Hiddink?

Singapore/Taiwan consecutively invited MEDIPOST to its stem cell forums

MEDIPOST Obtains Patent in US for its Arthritis Treatment Technique

MEDIPOST’s Stem Cell Drug ‘CARTISTEM’ Hits 5,000 Sales Mark

Chinese Securities Company Praises MEDIPOST as a “Company with Most Profitable Stem Cell Drug”

MEDIPOST Begins Sales of its Stem Cell Drug, ‘CARTISTEM’

MEDIPOST Obtains Patent for its ‘CARTISTEM’ Production Technology’ in Six European Countries

MEDIPOST’s Stem Cell Technology Covered in Depth by Taiwanese News Channel FTV

Significant increase in the revenue of MEDIPOST stem cell therapeutics CARTISTEM in comparison to the previous year

MEDIPOST acquires the patent in Mexico for ‘CARTISTEM’

MEDIPOST, signs a contract with SK Bioland for an ankle joint indication